title: A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.
authors.affiliation: Abteilung Innere Medizin III, Medizinische Universitätsklinik, Ulm, Federal Republic of Germany.
authors.forename: E
authors.initials: E
authors.lastname: Kurrle
authors.forename: G
authors.initials: G
authors.lastname: Ehninger
authors.forename: M
authors.initials: M
authors.lastname: Freund
authors.forename: G
authors.initials: G
authors.lastname: Heil
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
authors.forename: H
authors.initials: H
authors.lastname: Link
authors.forename: P S
authors.initials: PS
authors.lastname: Mitrou
authors.forename: S
authors.initials: S
authors.lastname: Ohl
authors.forename: W
authors.initials: W
authors.lastname: Queisser
authors.forename: G
authors.initials: G
authors.lastname: Schlimok
mesh_terms: D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007239:Infections / Q000139:chemically induced; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D012074:Remission Induction; D013921:Thrombocytopenia / Q000139:chemically induced
chemical_list: D003561:Cytarabine; D005047:Etoposide; D003630:Daunorubicin